Brief: Remus Pharmaceuticals Incorporates Subsidiary For Clinical Trial Material Management
20/06/2025 08:33
June 20 (Reuters) - Remus Pharmaceuticals Ltd REMP.NS: INCORPORATES SUBSIDIARY FOR CLINICAL TRIAL MATERIAL MANAGEMENT Source text: ID:nNSEbjVg2k Further company coverage: REMP.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Remus Pharmaceuticals
See all newsBrief: Remus Pharmaceuticals Appoints Bhavik Shah As CFO Effective July 09, 2026
Brief: Remus Pharmaceuticals Says Anjali Shah Resigns As CFO
Brief: Remus Pharmaceuticals Re-Appoints Arpit Shah As MD
Brief: Remus Pharmaceuticals Incorporates Subsidiary For Clinical Trial Material Management
Brief: Remus Pharmaceuticals Acquiring Membership Interest Of 56.67% In Espee Global Holdings